article thumbnail

Phil and Teva Pharmaceuticals Launch New Program to Improve Access to the Digihaler® Family of Inhalers to Support Asthma Management

Digital Health Global

Via the PhilRx Patient Access Platform, patients can now access Teva Pharmaceuticals’ Digihaler® family of inhalers SAN FRANCISCO–(BUSINESS WIRE)– Phil Inc., The goal of Phil and Teva Pharmaceuticals’ partnership is to help enable patients to receive and refill their Digihaler medication quickly, easily and affordably.

article thumbnail

Teva’s Digital Health Collaboration with Rimidi Expands to Include Respiratory Monitoring Program Integration with a Large U.S. Health System

Digital Health Global

–(BUSINESS WIRE)–Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. The platform can be used to monitor and manage large populations by a network of health systems, capturing objective and actionable data for asthma patients. About Teva Teva Pharmaceutical Industries Ltd.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Crossing the Chasm for Digital Therapeutics (DTx) in Pharmaceuticals

care innovations

Pharmaceuticals are no longer looking for a point-based product, but rather a group of services that engage patients in a way that increases adoption and adherence for medical purposes. One solution is digital therapeutics (DTx). About the author. Enrique Estrada is the Sr. 1 Frost & Sullivan.

article thumbnail

Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in Japan

Digital Health Global

And if approved in Japan, it will provide an effective and safe option in a country where some front line pharmaceutical therapies are not as widely available to pediatric patients with ADHD.” No safety concerns or serious adverse events related to SDT-001 were observed. No serious adverse events were associated with its use.

article thumbnail

Applications for Frontiers Health 2023 Start-up Discovery are now open

Digital Health Global

Do you have an innovative digital health solution? Then, don’t miss the opportunity to showcase it in Rome or online during the Frontiers Health 2023 Global Conference. Frontiers Health has demonstrated over the past seven editions that start-ups are a key catalyst for the development of a better healthcare experience.

article thumbnail

EVERSANA Completes Integration of Healthware Group and Strengthens Its Global Agency Network EVERSANA INTOUCH With Addition of New Full-Service Affiliate

Digital Health Global

Combined, the network helps pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, and solve unique geographic and market-specific challenges. They are, however, fully owned and operated by EVERSANA. To learn more about EVERSANA, visit eversana.com or connect through LinkedIn and X.

article thumbnail

EVERSANA Expands Global Commercialisation Capabilities and Strengthens Agency Network with Healthware Group Acquisition

Digital Health Global

The acquisition immediately expands EVERSANA’s European operations and worldwide capabilities to help pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, or solve unique geographic and market-specific challenges. Financial details of the acquisition are not being disclosed.